An Intergenerational Precision Medicine Research Program for the Study of Factor VIII Immunogenicity in Severe Hemophilia A: Hemophilia A Analytical Cohort Research Program (UG3/UH3 Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-22-004 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support applications that propose the establishment of a Hemophilia A Analytical Cohort Research Program (HARP) that will: 1) collaborate with an established consortium of clinical centers to support the recruitment, enrollment, and follow-up of an antenatal/ neonatal/ pediatric cohort in severe hemophilia A; 2) provide data management, laboratory, and biospecimen support necessary for the establishment of a unique and sharable biospecimen resource annotated with robust intergenerational clinical and demographic ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 9, 2021 Category: Research Source Type: funding

Request for Information (RFI): Interest in data and specimens from the Hemophilia Growth and Development Study (HGDS) for research on HIV-associated comorbidities, coinfections and complications
Notice NOT-HL-19-747 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 21, 2020 Category: Research Source Type: funding

Notice of Intent to Publish a Funding Opportunity Announcement for Generate A Precision Medicine Intergenerational Resource for the Study of Factor VIII Immunogenicity in Severe Hemophilia A:Clinical Coordinating Center
Notice NOT-HL-19-726 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 19, 2019 Category: Research Source Type: funding

Notice of Intent to Publish a Funding Opportunity Announcement for Generate an Intergenerational Precision Medicine Resource for the Study of Factor VIII Immunogenicity in Severe Hemophilia A: Biospecimen and Data Resource Center (U24)
Notice NOT-HL-19-727 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 19, 2019 Category: Research Source Type: funding

Request for Information (RFI): Soliciting Input for future research at the National Heart, Lung, and Blood Institute on Factor VIII (FVIII) immunogenicity and FVIII inhibitor prevention/eradication in patients with Hemophilia A
Notice NOT-HL-18-652 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 5, 2018 Category: Research Source Type: funding

Establishment of Research Centers to Investigate the FVIII Immune Response in Patients with Hemophilia A (U54)
Funding Opportunity ID: 292895 Opportunity Number: RFA-HL-18-014 Opportunity Title: Establishment of Research Centers to Investigate the FVIII Immune Response in Patients with Hemophilia A (U54)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.839Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal...
Source: Grants.gov - March 30, 2017 Category: Research Tags: Health Source Type: funding

Establishment of Research Centers to Investigate the FVIII Immune Response in Patients with Hemophilia A (U54)
Funding Opportunity RFA-HL-18-014 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to establish up to four Centers for the Investigation of Factor VIII immunogenicity (FVIII Centers). These Centers will utilize cross-disciplinary science and novel technologies to define the basic mechanisms involved in the development of anti-FVIII neutralizing antibodies, also known as FVIII inhibitors, in patients with congenital hemophilia A. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 30, 2017 Category: Research Source Type: funding

Centers for the Investigation of Factor VIII (FVIII) Immune Response in Patients with Hemophilia A (U54) FOA
Opportunity ID: 291601 Opportunity Number: NOT-HL-17-484 Opportunity Title: Centers for the Investigation of Factor VIII (FVIII) Immune Response in Patients with Hemophilia A (U54) FOAOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.837Eligible Applicants: Additional Information on Eligibility: Agency Code: HHS-NIH11Agency Name: Department of Health and Human ServicesNational Institutes of HealthPosted Date: Feb 03, 2017Last Updated Date: Feb 03, 2017Estimat...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Health Source Type: funding

Centers for the Investigation of Factor VIII (FVIII) Immune Response in Patients with Hemophilia A (U54) FOA
Notice NOT-HL-17-484 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 27, 2017 Category: Research Source Type: funding

Regional Hemophilia Network
Funding Opportunity ID: 286979 Opportunity Number: HRSA-17-074 Opportunity Title: Regional Hemophilia NetworkOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: https://grants.hrsa.gov/2010/Web2External/Interface/FundingCycle/ExternalView.aspx?fCycleID=b1459a1d-3397-401a-8ba2-bd53829fb76cCFDA Number(s): 93.110Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: Per 42 CFR ยง 51a.3(a), any ...
Source: Grants.gov - August 5, 2016 Category: Research Tags: Health Source Type: funding

National Hemophilia Program Coordinating Center
Funding Opportunity ID: 286919 Opportunity Number: HRSA-17-087 Opportunity Title: National Hemophilia Program Coordinating CenterOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: https://grants.hrsa.gov/2010/Web2External/Interface/FundingCycle/ExternalView.aspx?fCycleID=656fcd49-f433-43d4-8427-1e1d4d965a98CFDA Number(s): 93.110Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: Per 42 C...
Source: Grants.gov - August 4, 2016 Category: Research Tags: Health Source Type: funding

Public Health Surveillance for the Prevention of Complications of Bleeding Disorders
Funding Opportunity Number: CDC-RFA-DD15-1507 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.080Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: HHS-CDCClosing Date: May 20, 2015Award Ceiling: $4,300,000Expected Number of Awards: 1Creation Date: Mar 13, 2015Funding Opportunity Description: Since the 1990s the congressional budget has included funds for the the Centers f...
Source: Grants.gov - March 13, 2015 Category: Research Tags: Health Source Type: funding

National Hemophilia Program Coordinating Center
Funding Opportunity Number: HRSA-15-087 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.110Eligible Applicants Native American tribal organizations (other than Federally recognized tribal governments)Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-HRSAClosing Date: Feb 23, 2015Award Ceiling: $0Expected Number of Awards: 1Creation Date: Dec 23, 2014Funding Opportunity Description: This announcement solicits applications for the National Here...
Source: Grants.gov - December 24, 2014 Category: Research Tags: Health Source Type: funding

2015 Hemostasis and Thrombosis Research Society/Novo Nordisk Clinical Fellowship Awards in Hemophilia and Rare Bleeding Disorders
The Hemostasis and Thrombosis Research Society (“HTRS”) and Novo Nordisk Inc. (“Novo Nordisk”) announce the availability of two awards in 2015 for clinical fellowships focused on hemophilia and rare bleeding disorders for one academic year (July 1, 2015 - June 30, 2016). During the fellowship year, awardees are mentored by experienced MDs or DOs working in hemophilia or rare bleeding disorders at established U.S. hemostasis treatment centers (“HTCs”). Eligibility Applicants must be adult or pediatric hematology/oncology MDs or DOs who will have completed a fellowship in ...
Source: ScanGrants feed - October 28, 2014 Category: Research Authors: Hemostasis and Thrombosis Research Society/Novo Nordisk Source Type: funding